Live Faecalibacterium prausnitzii in an apical anaerobic model of the intestinal epithelial barrier

Faecalibacterium prausnitzii, an abundant member of the human commensal microbiota, has been proposed to have a protective role in the intestine. However, it is an obligate anaerobe, difficult to co‐culture in viable form with oxygen‐requiring intestinal cells. To overcome this limitation, a unique apical anaerobic model of the intestinal barrier, which enabled co‐culture of live obligate anaerobes with the human intestinal cell line Caco‐2, was developed. Caco‐2 cells remained viable and maintained an intact barrier for at least 12 h, consistent with gene expression data, which suggested Caco‐2 cells had adapted to survive in an oxygen‐reduced atmosphere. Live F. prausnitzii cells, but not ultraviolet (UV)‐killed F. prausnitzii, increased the permeability of mannitol across the epithelial barrier. Gene expression analysis showed inflammatory mediators to be expressed at lower amounts in Caco‐2 cells exposed to live F. prausnitzii than UV‐killed F. prausnitzii, This, consistent with previous reports, implies that live F. prausnitzii produces an anti‐inflammatory compound in the culture supernatant, demonstrating the value of a physiologically relevant co‐culture system that allows obligate anaerobic bacteria to remain viable.

[1]  P. Rutgeerts,et al.  Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease , 2002, American Journal of Gastroenterology.

[2]  R. Ley,et al.  Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.

[3]  B. Ramakrishna.  The Normal Bacterial Flora of the Human Intestine and Its Regulation , 2007 .

[4]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[5]  N. Roy,et al.  Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function. , 2010, FEMS microbiology letters.

[6]  H. Harmsen,et al.  Cultured Representatives of Two Major Phylogroups of Human Colonic Faecalibacterium prausnitzii Can Utilize Pectin, Uronic Acids, and Host-Derived Substrates for Growth , 2011, Applied and Environmental Microbiology.

[7]  H. Sokol,et al.  Faecalibacterium prausnitzii and human intestinal health. , 2013, Current opinion in microbiology.

[8]  M. Balda,et al.  Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical- basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein , 1996, The Journal of cell biology.

[9]  Gordon K Smyth,et al.  Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2004, Statistical applications in genetics and molecular biology.

[10]  K. Barrett,et al.  Probiotic inhibition of the entry of enteroinvasive E. coli into, human intestinal epithelial cells involves both Rho-dependent and -independent pathways , 2003 .

[11]  Harry J Flint,et al.  The gut anaerobe Faecalibacterium prausnitzii uses an extracellular electron shuttle to grow at oxic–anoxic interphases , 2012, The ISME Journal.

[12]  Mario Vaneechoutte,et al.  Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora , 2008, Inflammatory bowel diseases.

[13]  H. Flint,et al.  Cultivable bacterial diversity from the human colon , 2007, Letters in applied microbiology.

[14]  J. Pouysségur,et al.  Hypoxia in cancer cell metabolism and pH regulation. , 2007, Essays in biochemistry.

[15]  H. Harmsen,et al.  Antioxidants Keep the Potentially Probiotic but Highly Oxygen-Sensitive Human Gut Bacterium Faecalibacterium prausnitzii Alive at Ambient Air , 2014, PloS one.

[16]  S. Reichenbach,et al.  Inhibition of the TNF-pathway: use of infliximab and etanercept as remission-inducing agents in cases of therapy-resistant chronic inflammatory disorders. , 2002, Swiss medical weekly.

[17]  J. Doré,et al.  Highlighting new phylogenetic specificities of Crohn's disease microbiota , 2011, Inflammatory bowel diseases.

[18]  Peter van Baarlen,et al.  Epithelial crosstalk at the microbiota–mucosal interface , 2010, Proceedings of the National Academy of Sciences.

[19]  Christopher J. Schofield,et al.  Oxygen sensing by HIF hydroxylases , 2004, Nature Reviews Molecular Cell Biology.

[20]  H. Harmsen,et al.  How can Faecalibacterium prausnitzii employ riboflavin for extracellular electron transfer? , 2012, Antioxidants & redox signaling.

[21]  E. P. Cato,et al.  Fusobacterium prausnitzii (Hauduroy et al.) Moore and Holdeman: Emended Description and Designation of Neotype Strain , 1974 .

[22]  H. Harmsen,et al.  Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. , 2002, International journal of systematic and evolutionary microbiology.

[23]  R. Knight,et al.  Diversity, stability and resilience of the human gut microbiota , 2012, Nature.

[24]  H. Sokol,et al.  The Commensal Bacterium Faecalibacterium prausnitzii Is Protective in DNBS-induced Chronic Moderate and Severe Colitis Models , 2014, Inflammatory bowel diseases.

[25]  C. Michiels,et al.  Reciprocal influence of the p53 and the hypoxic pathways , 2011, Cell Death and Disease.

[26]  W E Moore,et al.  Intestinal floras of populations that have a high risk of colon cancer , 1995, Applied and environmental microbiology.

[27]  S. Colgan,et al.  Autocrine regulation of epithelial permeability by hypoxia: role for polarized release of tumor necrosis factor alpha. , 1998, Gastroenterology.

[28]  Y. Sanz,et al.  Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children , 2010, BMC Microbiology.

[29]  G. Semenza,et al.  Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. , 2005, Blood.

[30]  G. Oberhuber,et al.  Changes in Gastrointestinal Permeability in Celiac Disease , 1998, Digestive Diseases.

[31]  R. Hershberg,et al.  Critical Role of cAMP Response Element Binding Protein Expression in Hypoxia-elicited Induction of Epithelial Tumor Necrosis Factor-α* , 1999, The Journal of Biological Chemistry.